MWA
Sponsors
The University of Texas Health Science Center, Houston, Chinese PLA General Hospital, Fan Weijun, Rigshospitalet, Denmark, Shanghai Chest Hospital
Conditions
Colorectal CarcinomaCopdEarly Hepatocellular CarcinomaHepatocellular CancerHepatocellular CarcinomaHepatocellular Carcinoma Non-resectableLiver MetastasesLung Cancer
Phase 2
Combination Therapy of Microwave Ablation and Cellular Immunotherapy for Hepatocellular Carcinoma
CompletedNCT02851784
Start: 2009-12-31End: 2021-03-01Updated: 2021-03-04
Microwave Ablation Versus Stereotactic Body Radiotherapy for Colorectal Liver Metastases in Oligometastatic Disease: a Prospective, Randomised, Phase 2 Trial
Active, not recruitingNCT03654131
Start: 2018-07-25End: 2029-12-03Updated: 2026-03-19
Unknown Phase
Prospective Tumor Response Evaluation
TerminatedNCT02787954
Start: 2016-01-31End: 2017-04-30Updated: 2018-10-18
Microwave Ablation Combined With TACE in the Treatment of Unresectable Huge Hepatocellular Carcinoma Huge
NCT03277716
Start: 2017-12-01End: 2021-12-30Target: 100Updated: 2019-05-07
ENB Guided MWA for Early-stage Peripheral Lung Cancer
NCT04005157
Start: 2018-04-18End: 2020-06-30Target: 60Updated: 2020-01-10
The Efficacy and Safety of EOB-MRI Guided Microwave Ablation for Early HCC: A Multicenter, Prospective, Observational Study
Active, not recruitingNCT06096896
Start: 2023-08-30End: 2030-09-30Target: 334Updated: 2023-10-24
Comparing BTVA and MWA in COPD With Early Lung Cancer: Efficacy and Safety
Not yet recruitingNCT06929390
Start: 2025-05-01End: 2028-12-31Target: 26Updated: 2025-04-18
MWA With or Without Furmonertinib for Early-Stage Non-Small Cell Lung Cancer
Not yet recruitingNCT06969781
Start: 2025-05-31End: 2028-12-31Target: 120Updated: 2025-05-14